Skip to main content
Skip to content

Copper

Trace minerals
Iron metabolism

Your intake

Today (logged)
0 mg
0% of 0.9 mg
Stack potential
0 mg
0% of 0.9 mg
Target
0.9 mg
FDA Daily Value
Where you are on the ladder0% of target

What each level of copper does

Approximate dose-response bands. Individual response varies — these are starting points, not prescriptions.

  1. Severely lowYOU ARE HERE
    0 mg0.3 mg

    Well below target. Risk of deficiency symptoms tied to iron metabolism.

  2. Insufficient
    0.3 mg0.9 mg

    Below the recommended daily target. Long-term adequacy not assured.

  3. Adequate
    0.9 mg1.35 mg

    Daily target met. Standard nutritional support for iron metabolism.

  4. Therapeutic
    1.35 mg1.8 mg

    Common for specific health goals. Check the evidence for your situation before sustaining this level.

  5. High
    1.8 mg10 mg

    Approaching the tolerable upper limit. Monitor and consider clinical guidance.

  6. Over upper limit
    10 mg+

    Above the tolerable upper limit. Risk of adverse effects — back off or consult a clinician.

Overview

Trace mineral required for iron metabolism, connective tissue, neurotransmitter synthesis, and antioxidant defence. Body content is small (~80 mg, mostly liver and brain). Most often discussed in the context of zinc supplementation — chronic high-dose zinc depletes copper, with consequences ranging from microcytic anemia to myelopathy.

Functions

  • Cofactor for ceruloplasmin (iron oxidation/transport)
  • Cofactor for lysyl oxidase (collagen/elastin cross-linking)
  • Cofactor for cytochrome c oxidase (mitochondrial complex IV)
  • Cofactor for superoxide dismutase 1 (antioxidant)
  • Cofactor for dopamine beta-hydroxylase (norepinephrine synthesis)
  • Cofactor for tyrosinase (melanin synthesis)

Mechanism

Copper cycles between Cu+ and Cu2+ states, accepting and donating electrons in metalloenzymes. Ceruloplasmin uses copper to oxidise Fe2+ to Fe3+ for transport on transferrin — explaining why copper deficiency mimics iron deficiency anemia (refractory to iron alone). Wilson disease (ATP7B mutation) causes copper accumulation in liver and brain; Menkes disease (ATP7A) causes systemic copper deficiency.

Benefits

  • Treatment of copper-deficiency anemia and neutropenia (often after bariatric surgery or chronic zinc)
  • Required for normal melanin and connective tissue formation
  • Component of AREDS formula for AMD

Deficiency

Spontaneous deficiency is rare in unsupplemented adults but is increasingly recognised after gastric bypass, with long-term zinc supplementation, and in malabsorption.

Signs
  • Microcytic or normocytic anemia (refractory to iron)
  • Neutropenia
  • Myelopathy — gait ataxia, sensory loss (mimics B12 deficiency)
  • Hypopigmentation
  • Osteoporosis
  • Hypercholesterolemia
At-risk groups
  • Chronic high-dose zinc supplementation (>40 mg/day)
  • Bariatric surgery (especially gastric bypass)
  • Malabsorption (celiac, IBD)
  • Excessive denture-cream use (older zinc-containing brands)
  • Menkes disease (genetic)

Excess

Acute toxicity from copper-contaminated water or supplements causes GI distress; chronic excess (Wilson disease) drives hepatic and neurological damage.

Signs
  • Nausea, vomiting, abdominal pain (acute)
  • Hepatic damage, hemolytic anemia
  • Neurological symptoms (Wilson disease)
  • Kayser-Fleischer corneal rings (Wilson)

Forms

  • Copper bisglycinate
    Chelated, well-absorbed; preferred supplement form
  • Copper sulfate
    Inexpensive, well-absorbed; mild GI
  • Copper gluconate
    Common in multivitamins
  • Cupric oxide
    Cheap; very poorly bioavailable; avoid as primary source

Food sources

  • Beef liver (cooked) · 3 oz12 mg
  • Oysters (cooked) · 3 oz4 mg
  • Cashews · 1 oz0.6 mg
  • Sunflower seeds · 1 oz0.5 mg
  • Dark chocolate (70%+) · 1 oz0.5 mg
  • Cooked shiitake mushrooms · 1/2 cup0.65 mg

Supplement forms

Copper bisglycinate or copper sulfate at 1–2 mg/day is sufficient as a counterweight to zinc supplementation. A common ratio is 1 mg copper per 10–15 mg zinc when both are supplemented chronically.

Bioavailability

~25–55% absorbed in proximal small intestine; absorption is upregulated when stores are low. High-dose zinc induces metallothionein in enterocytes, which traps copper and prevents transfer to blood — the mechanism behind zinc-induced copper deficiency.

Longevity relevance

Adequacy supports iron metabolism, antioxidant defence (Cu-Zn SOD), and connective tissue (lysyl oxidase). Modest deficiency is increasingly common in older adults on chronic zinc and may contribute to anemia and neurological symptoms typically attributed to other causes.

Relationships

Synergies (works better with)
  • Iron · Ceruloplasmin needs copper to mobilise iron — copper deficiency causes refractory anemia
  • Zinc · Together support Cu-Zn superoxide dismutase activity; balance matters
  • Vitamin C · Cofactor in connective tissue alongside lysyl oxidase
Antagonists (competes with / inhibited by)
  • Zinc (high dose) · Induces enterocyte metallothionein; traps copper; the most common cause of acquired Cu deficiency
  • Iron (very high dose) · Competitive absorption; usually only matters at pharmacological iron levels
  • Molybdenum (very high) · Forms thiomolybdates that bind copper; medically exploited in Wilson disease (tetrathiomolybdate)
  • Antacids, vitamin C megadose · Modestly reduce absorption

References

About Copper

Cytochrome c oxidase, ceruloplasmin, iron transport.

Role
Iron metabolism
Daily target
0.9 mg (DV)
Upper limit
10 mg
Also called
copper, copper bisglycinate, copper sulfate, copper gluconate
Click here to learn more about Copper
Full explainer on Formulate Health — mechanisms, who's commonly deficient, food sources, evidence for supplementation.
How Copper acts on the body

The mechanisms and systems this nutrient feeds. Click any to drill into what runs on it.